[Sofia, Bulgaria] — Comac Medical is proud to announce the appointment of Peter Windisch as its new Chief Operations Officer (COO). With nearly 30 years of expertise in clinical research and trial management, Peter brings a wealth of knowledge, innovative vision, and a proven record of driving operational excellence in the healthcare and biotechnology sectors.
Peter Windisch: A Leader in Innovation and Operational Excellence
Peter demonstrates exceptional strategic leadership, adept at aligning teams and resources to drive operational success. With comprehensive experience in clinical research, he excels in project management, data handling, and delivering streamlined clinical trial outcomes. Drawing on a strong foundation in IT and data management, Peter consistently leverages technological innovation to optimize processes and enhance trial results. Furthermore, he has a proven track record in change management, successfully leading organizational transformations to boost efficiency and implement continuous improvement strategies.
Peter is a dynamic executive known for building high-performing teams and fostering environments that attract top talent and sponsor partnerships. His career spans a diverse array of expertise, including clinical operations, program management, data integration, and IT systems aimed at delivering superior quality and efficiency in clinical trials.
Career Highlights
As CEO of a biotech company, Peter spearheaded AI-driven innovations to accelerate drug discovery and streamline clinical trials. In his role as a Technology and Operations Leader at a global CRO, he revolutionized clinical trial delivery through operational advancements. As VP of Operations for a multinational CRO, he successfully managed operations across Western Europe, ensuring excellence in clinical program execution. Additionally, as Managing Director at a clinical research company, Peter improved efficiency through strategic IT and data integration initiatives.
Peter’s leadership philosophy centers on fostering innovation, achieving operational excellence, and delivering outstanding client-focused services. His extensive expertise and ability to adapt in the ever-evolving clinical research landscape make him an ideal fit to lead Comac Medical’s operations.
“We are thrilled to welcome Peter Windisch to the Comac Medical family,” said Vladimir Goranov and Rossitsa Vrabevska, Co-CEOs of Comac Medical. “His forward-thinking approach and deep industry knowledge will strengthen our operational capabilities and drive our mission of delivering exceptional clinical research services.”
About Comac Medical
Comac Medical is a leading clinical research organization (CRO) and site management organization (SMO) with over 25 years of experience in delivering high-quality solutions for clinical trials. Headquartered in Europe, the company offers a full range of services across all phases of drug development, specializing in clinical operations, data management, regulatory affairs, and site management. Comac Medical partners with global pharmaceutical, biotechnology, and medical device companies to drive innovation, operational excellence, and improved patient outcomes, ensuring successful and efficient trial execution.
For more information contact marketing@comac-medical.com.
